ARCHIVES

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

PRI Fires Gilden, Compten, Sues For $1 Million By May Be Out Of Recompetition; NCI Is “Neutral”

August 8, 1986

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

Cell Culture ID Offered By NIC

January 7, 1983

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992